FDA warns vs fake versions of popular medicines | Inquirer News

FDA warns vs fake versions of popular medicines

/ 05:05 AM May 08, 2023

Composite photo of FDA building with logo superimposed. STORY: FDA warns vs fake versions of popular medicines

Photo from the Food and Drug Administration (FDA) official Facebook page

MANILA, Philippines — Counterfeit versions of some popular over-the-counter pain relievers and flu medicines are circulating in the market, the Food and Drug Administration (FDA) reported.

The FDA issued advisories on May 4 through its website warning consumers and pharmacies against fake versions of nine brands of medicines: Alaxan, Neozep Forte, Bioflu, Tuseran Forte, Ponstan, Diatabs, Kremil-S, Medicol Advance, and Lomotil.

Article continues after this advertisement

The FDA advisories showed photos of the authentic drug products alongside the counterfeit versions. The genuine and counterfeit medicines look almost the same except for some slight discoloration in the latter.

FEATURED STORIES

The FDA merely said: “The lot number, knurling and print appearance [of the counterfeit products] are not comparable with the standard features of the registered product.”

The FDA warned establishments and outlets from selling or dispensing counterfeit drug products. Violators face imprisonment ranging from six years up to 10 years and a fine of between P100,000 to P500,000 or both, for the manufacture, sale, or distribution of counterfeit drugs.

—DONA Z. PAZZIBUGAN

RELATED STORIES

Customs agents seize P30 million worth of fake medicines; nab suspect

FDA seeks banning ‘sari-sari’ stores from selling medicines

371 violative online posts selling medicines removed – FDA

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: fake medicines, Food and Drug Administration

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.